Rhodiola rosea is an herb purported to possess adaptogenic and ergogenic properties and has recently been the subject of increased interest. The purpose of this article was to review and summarize recent investigations of the potential performance-enhancing properties of Rhodiola rosea. Such studies have generated equivocal results. Several investigations conducted in Eastern Europe have indicated that Rhodiola rosea ingestion may produce such positive effects as improved cognitive function and reduced mental fatigue. Other research from this region has illustrated enhanced endurance exercise performance in both humans and rats. Studies conducted in Western Europe and in North America have indicated that Rhodiola rosea may possess substantial antioxidant properties but have produced mixed results when attempting to demonstrate an ergogenic effect during exercise in humans.
Thomas B. Walker and Robert A. Robergs
Katrien De Bock, Bert O. Eijnde, Monique Ramaekers, and Peter Hespel
The purpose of this study was to investigate the effect of acute and 4-week Rhodiola rosea intake on physical capacity, muscle strength, speed of limb movement, reaction time, and attention.
PHASE I: A double blind placebo-controlled randomized study (n = 24) was performed, consisting of 2 sessions (2 days per session). Day 1: One hour after acute Rhodiola rosea intake (R, 200-mg Rhodiola rosea extract containing 3% rosavin + 1% salidroside plus 500 mg starch) or placebo (P, 700 mg starch) speed of limb movement (plate tapping test), aural and visual reaction time, and the ability to sustain attention (Fepsy Vigilance test) were assessed. Day 2: Following the same intake procedure as on day 1, maximal isometric knee-extension torque and endurance exercise capacity were tested. Following a 5-day washout period, the experimental procedure was repeated, with the treatment regimens being switched between groups (session 2). PHASE II: A double blind placebo-controlled study (n = 12) was performed. Subjects underwent sessions 3 and 4, identical to Phase I, separated by a 4-week R/P intake, during which subjects ingested 200 mg R/P per day.
PHASE I: Compared with P, acute R intake in Phase I increased 0 < -05) time to exhaustion from 16.8 ± 0.7 min to 17.2 ± 0.8 min. Accordingly, VO2peak (p < .05) and VCO2peak(p< .05) increased during R compared to P from 50.9 ± 1.8 ml • min-1 • kg−1 to 52.9 ± 2.7 ml • min-1 • kg"’ (VO2peak) and from 60.0 ± 2.3 ml • min-1 • kg-’ to 63.5 ± 2.7 ml • min-1 kg-1 (VCO2peak). Pulmonary ventilation (p = .07) tended to increase more during R than during P(P: 115.9±7.7L/min; R: 124.8 ± 7.7 L/min). All other parameters remained unchanged. PHASE II: Four-week R intake did not alter any of the variables measured.
Acute Rhodiola rosea intake can improve endurance exercise capacity in young healthy volunteers. This response was not altered by prior daily 4-week Rhodiola intake.